Literature DB >> 8491179

Protease-nexin I as an androgen-dependent secretory product of the murine seminal vesicle.

J D Vassalli1, J Huarte, D Bosco, A P Sappino, N Sappino, A Velardi, A Wohlwend, H Ernø, D Monard, D Belin.   

Abstract

A search for inhibitors of urokinase-type plasminogen activator (uPA) in the male and female murine genital tracts revealed high levels of a uPA ligand in the seminal vesicle. This ligand is functionally, biochemically and immunologically indistinguishable from protease-nexin I (PN-I), a serpin ligand of thrombin and uPA previously detected only in mesenchymal cells and astrocytes. A survey of murine tissues indicates that PN-I mRNA is most abundant in seminal vesicles, where it represents 0.2-0.4% of the mRNAs. PN-I is synthesized in the epithelium of the seminal vesicle, as determined by in situ hybridization, and is secreted in the lumen of the gland. PN-I levels are much lower in immature animals, and strongly decreased upon castration. Testosterone treatment of castrated males rapidly restores PN-I mRNA levels, indicating that PN-I gene expression is under androgen control.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491179      PMCID: PMC413407          DOI: 10.1002/j.1460-2075.1993.tb05835.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  46 in total

1.  Effects of androgens on the transcription of secretory protein genes in rat seminal vesicle.

Authors:  S J Higgins; A L Hemingway
Journal:  Mol Cell Endocrinol       Date:  1991-04       Impact factor: 4.102

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Inhibition of protease activity can lead to neurite extension in neuroblastoma cells.

Authors:  D Monard; E Niday; A Limat; F Solomon
Journal:  Prog Brain Res       Date:  1983       Impact factor: 2.453

4.  Released protease-nexin regulates cellular binding, internalization, and degradation of serine proteases.

Authors:  D A Low; J B Baker; W C Koonce; D D Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

Review 5.  Protein inhibitors of proteinases.

Authors:  M Laskowski; I Kato
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

6.  Effect of castration on the synthesis of seminal vesicle secretory protein IV in the rat.

Authors:  M C Ostrowski; M K Kistler; W S Kistler
Journal:  Biochemistry       Date:  1982-07-20       Impact factor: 3.162

7.  Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells.

Authors:  J B Baker; D A Low; R L Simmer; D D Cunningham
Journal:  Cell       Date:  1980-08       Impact factor: 41.582

8.  Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse.

Authors:  L I Larsson; L Skriver; L S Nielsen; J Grøndahl-Hansen; P Kristensen; K Danø
Journal:  J Cell Biol       Date:  1984-03       Impact factor: 10.539

9.  Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin.

Authors:  D L Eaton; J B Baker
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

10.  Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.

Authors:  J D Vassalli; J M Dayer; A Wohlwend; D Belin
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  17 in total

1.  The use of RNA probes for the analysis of gene expression.

Authors:  D Belin
Journal:  Mol Biotechnol       Date:  1997-04       Impact factor: 2.695

2.  Male fertility defects in mice lacking the serine protease inhibitor protease nexin-1.

Authors:  V Murer; J F Spetz; U Hengst; L M Altrogge; A de Agostini; D Monard
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

3.  Protease nexin I (PNI) in mouse brain is expressed from the same gene as in seminal vesicle.

Authors:  B A Citron; K T Ratzlaff; I V Smirnova; B W Festoff
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

4.  Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.

Authors:  C Barazzone; D Belin; P F Piguet; J D Vassalli; A P Sappino
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

5.  The kidney is a major site of alpha(2)-antiplasmin production.

Authors:  P A Menoud; N Sappino; M Boudal-Khoshbeen; J D Vassalli; A P Sappino
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

6.  The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis.

Authors:  Sébastien Bergeron; Etienne Lemieux; Véronique Durand; Sébastien Cagnol; Julie C Carrier; Jacques G Lussier; Marie-Josée Boucher; Nathalie Rivard
Journal:  Mol Cancer       Date:  2010-10-13       Impact factor: 27.401

7.  SERPINE2, an inhibitor of plasminogen activators, is highly expressed in the human endometrium during the secretory phase.

Authors:  Robert Kuo-Kuang Lee; Chi-Chen Fan; Yuh-Ming Hwu; Chung-Hao Lu; Ming-Huei Lin; Ying-Jie Chen; Sheng-Hsiang Li
Journal:  Reprod Biol Endocrinol       Date:  2011-03-23       Impact factor: 5.211

8.  Molecular organization of the rat glia-derived nexin/protease nexin-1 promoter.

Authors:  H Ernø; D Monard
Journal:  Gene Expr       Date:  1993

9.  Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: functional redundancy among physiological plasminogen activators.

Authors:  G Leonardsson; X R Peng; K Liu; L Nordström; P Carmeliet; R Mulligan; D Collen; T Ny
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

10.  Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis.

Authors:  Joanna Selzer-Plon; Jette Bornholdt; Stine Friis; Hanne C Bisgaard; Inger Mb Lothe; Kjell M Tveit; Elin H Kure; Ulla Vogel; Lotte K Vogel
Journal:  BMC Cancer       Date:  2009-06-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.